1. What is a biosimilar drug?

A biosimilar drug is a biological drug similar to an approved biological original drug (hereinafter collectively referred to as "reference drug"), which is highly similar in quality, safety, and effectiveness to the approved original drug. Biosimilars and reference drugs can be compared to different "fruits" on a tree, they look the same and have the same nutritional content.

2. Advantages of biosimilar drugs

The significance of biosimilars is mainly reflected in the benefits of three aspects:

（1） Racial advantage

Taking adalimumab as an example, the original drug is imported from the United States, and there will be differences in race and physique in clinical research, while domestic biosimilar drugs are mainly used for clinical research on Chinese or Asians.

（2）Economic advantages

Biosimilar drugs have economic advantages, and the price of biosimilar drugs will generally be lower than that of original drugs. The entry of biosimilars into the pharmaceutical market can lead to healthy competition, help patients reduce personal treatment costs and medical insurance expenditures in all aspects, and allow more patients who cannot choose biological therapy due to economic reasons to obtain more treatment opportunities, thereby improving their quality of life.

（3） Benign optimization to reduce pain at the injection site

There are foreign clinical studies that report various causes of subcutaneous injection pain, and citric acid in excipients is one of the key factors causing pain. The pain of drugs with low concentration/no citric acid is significantly lower than that of drugs with higher concentration of citric acid. A group.

Some biosimilars have a benign optimization of excipients, which do not contain citric acid. Under the premise of ensuring that the clinical effectiveness and safety are highly similar to those of the original drug, it optimizes the buffer prescription to minimize the pain of injection for patients.

3. Biosimilar (Anitibodies) Supplier - Minbiotch

Shanghai Minbiotch Co., Ltd. is a company specializing in the research, development and production of advanced pharmaceutical intermediates and biological raw materials. The main products are monoclonal antibodies, ADC small molecule toxins, anti-COVID-19 raw materials, mRNA nucleosides required for vaccine production, and a variety of high-end generic and innovative drugs. Besides Biosimilar(Anitibodies), we also provide Nucleoside, Anti-infection, etc.